Standard Biotools (LAB) Intangibles (2016 - 2025)
Standard Biotools has reported Intangibles over the past 12 years, most recently at $28.1 million for Q1 2025.
- Quarterly Intangibles rose 13.16% to $28.1 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $28.1 million through Mar 2025, up 13.16% year-over-year, with the annual reading at $29.0 million for FY2024, 1968.14% up from the prior year.
- Intangibles was $28.1 million for Q1 2025 at Standard Biotools, down from $29.0 million in the prior quarter.
- Over five years, Intangibles peaked at $37.0 million in Q1 2021 and troughed at $1.4 million in Q4 2023.
- The 5-year median for Intangibles is $24.1 million (2024), against an average of $20.6 million.
- Year-over-year, Intangibles plummeted 88.89% in 2023 and then soared 1968.14% in 2024.
- A 5-year view of Intangibles shows it stood at $27.9 million in 2021, then plummeted by 54.88% to $12.6 million in 2022, then plummeted by 88.89% to $1.4 million in 2023, then soared by 1968.14% to $29.0 million in 2024, then fell by 3.1% to $28.1 million in 2025.
- Per Business Quant, the three most recent readings for LAB's Intangibles are $28.1 million (Q1 2025), $29.0 million (Q4 2024), and $20.0 million (Q3 2024).